North America Contrast Enhanced Ultrasound Market Forecast 2022-2030
KEY FINDINGS
The North America contrast enhanced ultrasound market is anticipated to surge with a 5.36% CAGR between the assessment period, 2030. Enhanced use of contrast ultrasound for abdominal and cardiac imaging, rising number of cases of chronic illness, and increasing education and training programs for radiologists and sonographers drive the market growth in the region.
MARKET INSIGHTS
The North America contrast enhanced ultrasound market growth assessment includes the evaluation of Canada and the United States. The Canada contrast enhanced ultrasound market demand is expected to surge owing to the expanding usage of contrast-enhanced ultrasound technology in cardiovascular and abdominal disorders.
Additionally, growing public and private investments in creating cutting-edge ultrasound technology, educational initiatives, and teleradiology services are predicted to support market expansion. Further, the Canadian government stated in January 2020 that it would invest $25 million in 14 new initiatives as a part of its digital technology supercluster strategy. The project’s goal was to provide bedside tools for medical professionals, portable ultrasound technology, and cloud-based platforms that might improve the scope of ultrasound services offered in Canada.
Furthermore, the increased prevalence of IBD and cardiovascular diseases is also anticipated to propel the demand for contrast-enhanced ultrasonography in Canada. Over 270,000 Canadians had IBD in 2018, and the Canadian Chronic Disease Surveillance System (CCDSS) of the Public Health Agency of Canada estimates that one in every 12 individuals had a heart disease diagnosis. This surge is anticipated to drive the contrast-enhanced ultrasound market in Canada.
COMPETITIVE Insights
Some of the leading market players are Bracco Diagnostic Inc and Lantheus Medical Imaging Inc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
- 1. Research Scope & Methodology
- 1.1. Study Objectives
- 1.2. Scope Of Study
- 1.3. Methodology
- 1.4. Assumptions & Limitations
- 2. Executive Summary
- 2.1. Market Size & Estimates
- 2.2. Market Overview
- 3. Market Dynamics
- 3.1. Key Drivers
- 3.1.1. Surging Prevalence Of Chronic Diseases
- 3.1.2. Health Practitioners Prefer Contrast-enhanced Ultrasound Imaging
- 3.1.3. Technological Advancements In Diagnosis
- 3.2. Key Restraints
- 3.2.1. Non-uniformity Of Contrast Agents
- 3.2.2. Difficulty In Adoption In The Current Healthcare System
- 4. Key Analytics
- 4.1. Impact Of Covid-19 On Contrast Enhanced Ultrasound Market
- 4.2. Key Market Trends
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Buyers Power
- 4.3.2. Suppliers Power
- 4.3.3. Substitution
- 4.3.4. New Entrants
- 4.3.5. Industry Rivalry
- 4.4. Opportunity Matrix
- 4.5. Vendor Landscape
- 4.6. Value Chain Analysis
- 4.7. Key Buying Criteria
- 4.7.1. Cost Efficiency
- 4.7.2. Product Features
- 4.7.3. End-use
- 4.8. Regulatory Framework
- 5. Market By Product
- 5.1. Equipment
- 5.2. Contrast Agent
- 6. Market By Type
- 6.1. Non-targeted
- 6.2. Targeted
- 7. Market By End-user
- 7.1. Hospitals
- 7.2. Clinics
- 7.3. Ambulatory Diagnostic Centers
- 8. Geographical Analysis
- 8.1. North America
- 8.1.1. Market Size & Estimates
- 8.1.2. Key Growth Enablers
- 8.1.3. Key Challenges
- 8.1.4. Key Players
- 8.1.5. Country Analysis
- 8.1.5.1. United States
- 8.1.5.2. Canada
- 9. Competitive Landscape
- 9.1. Key Strategic Developments
- 9.1.1. Mergers & Acquisitions
- 9.1.2. Product Launches & Developments
- 9.1.3. Partnerships & Agreements
- 9.1.4. Business Expansions & Divestitures
- 9.2. Company Profiles
- 9.2.1. Bayer Ag
- 9.2.2. Bracco Diagnostic Inc
- 9.2.3. Daiichi Sankyo Company Limited
- 9.2.4. Ge Healthcare
- 9.2.5. Koninklijke Philips Nv
- 9.2.6. Lantheus Medical Imaging Inc
- 9.2.7. Nanopet Pharma Gmbh
- 9.2.8. Sanochemia Pharmazeutika Gmbh
- 9.2.9. Shenzhen Mindray Bio-medical Electronics Co Ltd
- 9.2.10. Siemens Healthineers Ag
- 9.2.11. Taejoon Pharm
- 9.2.12. Trivitron Healthcare
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook